Myriad Genetics is a global leader in molecular diagnostics, dedicated to advancing precision medicine and improving patient outcomes. Our innovative solutions empower clinicians with actionable insights to guide cancer care. In 2026, we will introduce our Minimal Residual Disease (MRD) testing solution—a breakthrough in cancer monitoring and recurrence detection. Combined with our industry-leading hereditary cancer and tumor profiling tests, Myriad offers a comprehensive oncology portfolio that helps clinicians make confident, data-driven decisions. Position Summary As a Senior MRD Sales Executive , you will spearhead the introduction of MRD testing through a strategic, phased launch while driving adoption of Myriad’s full oncology portfolio. This role demands a consultative approach to educate healthcare providers on the clinical utility of MRD and integrate it into patient care pathways. This is an exciting opportunity to shape the future of cancer care by introducing a transformative technology and expanding our oncology solutions. You’ll join a team committed to innovation, collaboration, and improving patient outcomes. We know that exceptional people come from diverse paths. If you have experience selling high-impact medical technologies, educating clinicians, and shaping adoption in new or rapidly evolving markets, don’t second-guess yourself—your perspective may be exactly what we need. If you’re motivated by improving outcomes for cancer patients and want to be part of building something new, we welcome your application.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
1,001-5,000 employees